Midwest Financial Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-10,348
Closed -$264K 127
2025
Q3
$264K Sell
10,348
-200
-2% -$4.94K 0.13% 102
2025
Q2
$256K Buy
10,548
+318
+3% +$7.42K 0.13% 98
2025
Q1
$259K Sell
10,230
-600
-6% -$15.7K 0.15% 92
2024
Q4
$287K Sell
10,830
-4,014
-27% -$109K 0.17% 93
2024
Q3
$430K Buy
14,844
+1,340
+10% +$39.1K 0.25% 75
2024
Q2
$378K Sell
13,504
-100
-0.7% -$2.75K 0.24% 79
2024
Q1
$378K Buy
13,604
+873
+7% +$24.2K 0.25% 80
2023
Q4
$367K Sell
12,731
-7,561
-37% -$229K 0.27% 78
2023
Q3
$673K Sell
20,292
-26
-0.1% -$919 0.57% 50
2023
Q2
$745K Buy
20,318
+11,601
+133% +$452K 0.63% 46
2023
Q1
$356K Buy
+8,717
New +$376K 0.33% 72

Other funds holding PFE

Midwest Financial Group's PFE Position: Q4 2025 in Review

Midwest Financial Group sold out of Pfizer (PFE) in Q4 2025, closing a stake of 10,348 shares — an estimated $264K sold.

Midwest Financial Group first reported a position in PFE in Q1 2023 and held it in 11 quarters. The position peaked at $745K in Q2 2023. 2,915 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

  • Midwest Financial Group reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
  • Midwest Financial Group sold 10,348 Pfizer shares in Q4 2025, an estimated $264K.
  • Midwest Financial Group first reported a position in Pfizer in Q1 2023 and held it in 11 quarters.
  • Midwest Financial Group's Pfizer position peaked at $745K in Q2 2023.
  • 2,915 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on Midwest Financial Group's 13F filing for Q4 2025, filed 20 Jan 2026.